Journal de neurologie et neurosciences

  • ISSN: 2171-6625
  • Indice h du journal: 17
  • Note de citation du journal: 4.43
  • Facteur d’impact du journal: 3.38
Indexé dans
  • Ouvrir la porte J
  • Genamics JournalSeek
  • Le facteur d'impact global (GIF)
  • Infrastructure nationale des connaissances en Chine (CNKI)
  • Répertoire d'indexation des revues de recherche (DRJI)
  • OCLC - WorldCat
  • Invocation de Proquête
  • Facteur d'impact des revues scientifiques (SJIF)
  • Pub européen
  • Google Scholar
  • Laboratoires secrets des moteurs de recherche
Partager cette page

Abstrait

Myasthenia Gravis: Challenges and Therapeutics Solution

Sandeep Kumar Singh, Vijay Kumar and Ashok Kumar

Myasthenia gravis (MG) is an autoimmune disease leading to fluctuating muscle weakness and fatigability and patients have autoantibodies against the acetylcholine receptor. MG is a postsynaptic dis¬order caused by the antibody-mediated destruction of acetyl-choline receptors (AChRs) and blockage of the binding of acetylcholine to acetylcholine receptor. Lambert-Eaton myasthenic syndrome (LEMS) is distinct autoimmune disorders that affect neuromuscular transmission. A study by Jee-Ae Kim et al. showing same clinical features and electrophysiological finding in patients of MG and LEMS